When to See a Specialist: Differentiating Sensitivity from Celiac Disease

Coeliac disease is a well-characterised autoimmune condition in which the ingestion of gluten triggers an immune response that damages the villi — the finger-like projections that line the small intestine and are responsible for nutrient absorption. Managing this chronic inflammatory condition is well-supported by anti-inflammatory dietary principles that reduce systemic inflammation beyond just gluten avoidance. The process is driven by the interaction between gliadin peptides (derived from gluten) and tissue transglutaminase (tTG), an enzyme found in the intestinal lining. In genetically susceptible individuals (those carrying HLA-DQ2 or HLA-DQ8 gene variants), this complex is presented to the immune system as a foreign antigen, triggering the production of autoantibodies (anti-tTG IgA, anti-endomysial IgA) and an inflammatory response that progressively destroys the intestinal mucosa. The consequences of untreated coeliac disease extend far beyond intestinal symptoms: malabsorption of iron, calcium, folate, B12, vitamin D, and zinc creates a range of nutritional deficiencies; long-term intestinal inflammation increases the risk of osteoporosis, infertility, certain autoimmune conditions, and, in rare cases, intestinal lymphoma. Coeliac disease affects approximately 1% of the global population, though it remains significantly underdiagnosed — estimates suggest that only 10–30% of people with the condition have received a formal diagnosis. Classic presentation includes diarrhoea, bloating, weight loss, and anaemia, but atypical presentations — fatigue, mouth ulcers, dermatitis herpetiformis (an intensely itchy skin rash), joint pain, neurological symptoms, and infertility — are increasingly recognised and mean that a high clinical index of suspicion is warranted.

Non-coeliac gluten sensitivity (NCGS) is a condition in which individuals experience symptoms in response to gluten-containing foods that resolve on a gluten-free diet, but without the autoimmune mechanisms, intestinal villous atrophy, and specific antibodies that define coeliac disease. Symptoms of NCGS overlap significantly with coeliac disease — bloating, abdominal pain, fatigue, brain fog, joint pain, headache, and skin rash — and also with irritable bowel syndrome, making differential diagnosis challenging. NCGS lacks a definitive biomarker: there is no blood test or biopsy finding that confirms it, meaning that a diagnosis of NCGS is essentially reached by exclusion — ruling out coeliac disease (by blood test and biopsy) and wheat allergy (by IgE testing and skin prick test), then demonstrating symptom improvement on a gluten-free diet and symptom recurrence on gluten rechallenge. The mechanisms of NCGS are incompletely understood. Some research suggests that the immune activation involved is innate (involving Toll-like receptors and the release of interferons) rather than adaptive (T-cell and antibody-mediated), which would explain the absence of villous atrophy. There is also evidence that in some individuals diagnosed with NCGS, the symptoms may be driven primarily by wheat components other than gluten — particularly fructans (a type of FODMAP) or amylase-trypsin inhibitors (ATIs) — rather than gluten itself. This has therapeutic implications: some people with apparent NCGS may improve on a low-FODMAP diet rather than requiring strict gluten elimination.

Wheat allergy is distinct from both coeliac disease and NCGS in its mechanism: it is an IgE-mediated allergic reaction to wheat proteins (which may include gluten but also other wheat proteins such as omega-5-gliadin, a common trigger for wheat-dependent exercise-induced anaphylaxis). IgE-mediated reactions occur rapidly — typically within minutes to a few hours of wheat ingestion — and may include urticaria (hives), angioedema (swelling of the lips, tongue, or throat), rhinitis, asthma, gastrointestinal symptoms, or in severe cases, anaphylaxis. Wheat allergy is most common in children and frequently resolves by school age, though adult-onset wheat allergy exists and is associated with particular risk factors including occupational wheat exposure (baker's asthma is a well-described occupational condition). Wheat allergy is diagnosed by IgE blood testing (specific IgE or RAST testing) and/or skin prick testing, along with clinical history and, where necessary, a supervised oral food challenge. Management requires avoidance of wheat and may require carrying an adrenaline auto-injector (such as an EpiPen) in individuals with a history of severe reactions. Unlike coeliac disease, wheat allergy does not necessarily require avoidance of other gluten-containing grains (barley, rye) unless cross-reactivity is demonstrated — though this varies by individual and should be assessed clinically.

The diagnostic evaluation for gluten-related disorders should be conducted before initiating any dietary changes, as removing gluten prior to testing invalidates most diagnostic assessments. For suspected coeliac disease, the first-line investigation is a blood test measuring IgA anti-tissue transglutaminase antibodies (tTGA-IgA) — a sensitive and specific test that is the most widely used initial screen. If tTGA-IgA is elevated, or if there is strong clinical suspicion despite a negative test, referral to a gastroenterologist for upper gastrointestinal endoscopy with duodenal biopsy is the gold standard for confirmation, as biopsy allows direct assessment of villous atrophy (classified using the Marsh scale). Total IgA should be measured alongside the antibody test, as IgA deficiency (which affects approximately 2–3% of coeliac patients) produces a false-negative tTGA-IgA result; in this case, IgG-based antibody tests are used. HLA typing (DQ2/DQ8 status) is used primarily to rule out coeliac disease — the absence of both DQ2 and DQ8 makes coeliac disease extremely unlikely. For non-coeliac gluten sensitivity, no diagnostic test exists — diagnosis requires first excluding coeliac disease and wheat allergy, followed by a structured elimination and rechallenge protocol ideally supervised by a dietitian. For wheat allergy, IgE blood testing and skin prick testing are the primary diagnostic tools, interpreted in the context of clinical history.

Understanding precisely which gluten-related condition you have is not an academic exercise — it determines the strictness of dietary management required, the monitoring you need, the complications you face if the condition is poorly managed, and the support and resources available to you. It also informs whether a Mediterranean-style dietary framework can serve as the positive nutritional foundation alongside condition-specific restrictions. Coeliac disease requires absolute, lifelong gluten avoidance at or below 20 parts per million — even small amounts cause ongoing intestinal damage and maintain elevated autoantibody levels. It requires regular monitoring including annual blood tests for nutritional deficiencies (B12, folate, iron, vitamin D, calcium) and antibody levels; bone density scanning in adults at diagnosis and periodically thereafter; and in some cases, follow-up endoscopy to confirm mucosal healing. It also carries implications for first-degree relatives (parents, siblings, children), who have a 10–15% lifetime risk of developing coeliac disease and should be screened. Non-coeliac gluten sensitivity does not appear to cause intestinal damage or nutritional malabsorption in the same way as coeliac disease, and the degree of dietary strictness required is less clear — some individuals manage well with a low-gluten diet rather than a completely gluten-free one, though this should be individually assessed. Wheat allergy requires wheat avoidance but not necessarily avoidance of other gluten-containing grains. Its management includes an allergy action plan and, in high-risk individuals, an adrenaline auto-injector prescription.

The clearest indication for seeking specialist assessment is persistent or unexplained gastrointestinal symptoms — particularly diarrhoea, bloating, abdominal pain, or weight loss — accompanied by fatigue, anaemia, or other systemic symptoms that might suggest malabsorption. Skin manifestations such as dermatitis herpetiformis, unexplained joint pain, peripheral neuropathy, recurrent mouth ulcers, and unexplained infertility or recurrent pregnancy loss are all atypical presentations of coeliac disease that warrant screening. A family history of coeliac disease is itself a reason to request periodic screening even in the absence of symptoms, as silent coeliac disease (with villous atrophy but minimal symptoms) exists and still carries long-term health consequences. The diagnostic pathway typically begins with your GP, who can arrange the initial blood tests; if results are positive or equivocal, referral to a gastroenterologist for endoscopy and biopsy is the next step. On confirmation of coeliac disease, referral to a registered dietitian with expertise in coeliac disease is essential for initial dietary education and should not be considered optional. In the UK, a coeliac disease diagnosis also entitles you to annual review with a dietitian through the NHS and access to some prescription gluten-free foods. Connecting with Coeliac UK or your national equivalent patient organisation provides access to a food and drink directory, restaurant guides, and peer support networks.